Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...

Boyd Watterson Asset Management LLC OH trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 9.3% during ...

Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...

A turbulent series of events around the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around ...

In our latest round-up, we look at Amazon being set to launch ‘Low-Cost Store’, Arm cancelling an IP licence with Qualcomm, ...

The company is suing some online vendors and medical spas for selling copycats of a weight loss and diabetes drug.

The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of ...

Detailed price information for Inmed Pharmaceuticals Inc (INM-Q) from The Globe and Mail including charting and trades.

The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent.

Here's what happened, and why it's bullish for Lilly's stock.

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...